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There is substantial evidence that Ca2+ fluxes occur
during most forms of apoptosis, and that inhibiting
such fluxes protects cells from death. IP3 receptors —
ligand-gated channels that release Ca2+ from
intracellular stores — are emerging as key sites for
regulation by pro- and anti-apoptotic factors.
The cytosolic Ca2+ concentration in resting cells is
maintained at low levels (~100 nM) by enzymes that
translocate Ca2+ ions across the plasma membrane or
into intracellular stores. Ca2+ uptake into mitochondria
is another important way of removing cytosolic Ca2+
ions: by sequestering Ca2+ ions, mitochondria can mod-
ulate the kinetics and spatial dimensions of cellular Ca2+
signals [1]. Elevation of Ca2+ within the mitochondrial
matrix activates citric acid cycle enzymes and thereby
stimulates ATP production [2]. The cytosolic Ca2+ level
is increased physiologically when cells are challenged
with stimuli such as hormones, growth factors, depolar-
isation or mechanical deformation. The Ca2+ ions can
be released from intracellular stores, enter the cell
across the plasma membrane, or a combination of the
two. Cells employ a diverse range of messengers and
channels to access these sources [3]. For mobilising
Ca2+ stores, inositol 1,4,5-trisphosphate (IP3) receptors
are a principal route in almost all cell types. The release
of Ca2+ via IP3 receptors stimulates activities critical for
life, such as post-fertilization Ca2+ oscillations [4], but
under some conditions IP3 receptor-mediated Ca2+
signals are subverted to cause cell death.
IP3 receptors are large (~1200 kDa) tetrameric
proteins, each subunit of which projects an amino-
terminal domain into the cytoplasm, their membrane-
spanning carboxy-terminal regions forming an integral
Ca2+ channel. IP3 binding by the amino-terminal
domains causes a conformational change that pro-
motes channel opening. Between the IP3 binding site
and the transmembrane regions is a large stretch of
amino acids where a significant proportion of regulatory
interactions occur. Although IP3 is necessary to open
native IP3 receptors, activation of these channels is
complex and their open probability actually depends on
the ambient Ca2+ concentration. Up to ~500 nM, Ca2+
works synergistically with IP3 to activate IP3 receptors.
At higher concentrations, cytosolic Ca2+ inhibits IP3
receptor opening. The inhibition of IP3 receptors by
Ca2+ is thought to be a crucial mechanism for terminat-
ing channel activity and thus preventing pathological
Ca2+ rises.
IP3 Receptors in Apoptosis
A number of studies have shown that reducing IP3
receptor expression inhibits apoptosis. For example,
DT40 cells (a chicken B lymphoma cell line) in which IP3
receptor expression was prevented were not only defi-
cient in IP3-mediated Ca2+ signalling, but also substan-
tially resistant to the apoptosis normally induced in
response to B-cell receptor activation [5]. Similarly,
Jurkat cells with reduced expression of IP3 receptors
showed only a modest activation of caspases 3 and 9
following engagement of the CD3 component of the T-
cell receptor [6]. Caspases are aspartate-directed cys-
teine proteases responsible for a cascade of events that
culminate in cell death.
Three IP3 receptor isoforms have been cloned and
splice variants have been described, leading to the pos-
sibility that heteromultimeric channels are assembled
with distinctive properties relating to their subunit
content. At present, it is not clear whether different IP3
receptor isoforms have an equivalent role in apoptosis.
In the studies using DT40 cells, there appeared to be
redundancy between different IP3 receptor isoforms.
Cells where all three isoforms were knocked out
showed the least death compared to cells missing
either a single isoform or pairs of isoforms [5]. In
contrast to this, some studies have shown that
reduction of either type 1 or type 3 IP3 receptor
abrogates apoptosis.
How Does Ca2+ Cause Apoptosis?
Transfer of Ca2+ between intracellular stores and mito-
chondria provides physiological control of respiration.
But this Ca2+ cycle can also lead to cell death. If the
matrix Ca2+ level rises too high, or if normal Ca2+ signals
occur concurrently with production of molecules such
as arachidonate or ceramide, then deleterious changes
in mitochondrial structure may occur. In particular, mito-
chondria can swell and rupture or undergo permeability
transition, thereby releasing several pro-apoptotic
factors into the cytoplasm, such as cytochrome C,
second mitochondrial activator of caspases
(SMAC/Diablo) or apoptosis-inducing factor (AIF) [7].
This leads to the generation of the ‘apoptosome’ and
activation of caspases from inactive zymogens. It is well
established that Ca2+ released through IP3 receptors is
sequestered by mitochondria [2]. Furthermore, it has
been demonstrated that the flow of Ca2+ specifically
from IP3 receptors can cause mitochondrial permeabil-
ity transition and activate the apoptotic cascade [8].
In addition to directly feeding mitochondria with Ca2+,
activation of IP3 receptors can stimulate a variety of
Ca2+-sensitive enzymes that engage other apoptotic
mechanisms. One clear target of IP3-mediated Ca2+
signals is the phosphatase calcineurin. This enzyme has
many substrates, but in particular it can
dephosphorylate the pro-apoptotic protein Bad causing
it to translocate from the cytosol to mitochondria and
thereby stimulate cytochrome C release. T cells
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deficient in IP3 receptors were found to be resistant to
a variety of apoptotic stimuli; however, expression of a
constitutively active form of calcineurin or pharmaco-
logical elevation of Ca2+ could by-pass the need for IP3-
induced Ca2+ release and restore cell death [9].
How Are IP3 Receptors Activated during Apoptosis?
The physiological way of activating IP3 receptors, of
course, is to provoke intracellular production of IP3.
Natural IP3-generating agonists can induce apoptosis
under some conditions. In the case of immature B cells,
for example, apoptosis can be induced by IP3-mediated
Ca2+ signals arising from activation of the B-cell recep-
tor. This is essential to establish immunological self-tol-
erance. In contrast, with mature B cells, B-cell receptor
engagement provokes proliferation and antibody pro-
duction. In a similar vein, application of an IP3-generat-
ing agonist to mouse embryonic fibroblasts enhanced
apoptosis when it was applied concurrently with a pro-
apoptotic stimulus such as arachidonate [10].
Recent studies have demonstrated that IP3 receptors
can also be activated during apoptosis independently
of the production of IP3. In the case of type 1 IP3 recep-
tors, this may occur following proteolysis by activated
caspase 3. The type 1 IP3 receptor isoform has a single
highly conserved DEVD cleavage site, which is caspase
3 specific. Truncation of IP3 receptors by caspase 3 at
this position removes a large portion of the protein,
including the amino-terminal IP3-binding region and
other regulatory domains. The part that remains in the
endoplasmic reticulum (ER) membrane is a constitu-
tively active channel that continuously leaks Ca2+ [11]. 
The critical role of IP3 receptor cleavage by caspase
3 in apoptosis was recently demonstrated by Assefa et
al. [12]. They used DT40 cells in which all three IP3
receptor isoforms had been knocked out so that the
cells are insensitive to staurosporine: exogenous
expression of normal type 1 IP3 receptors — but not
mutant receptors that cannot be cut by caspase-3 —
restored sensitivity to staurosporine-induced apoptosis
[12]. Furthermore, expression of the ‘channel only’
domain produced following proteolysis of IP3 receptors
in the triple knock-out DT40 cells also sensitised them
to apoptosis.
Many pro-apoptotic stimuli, such as staurosporine,
cause Ca2+ signals as part of their mechanism of killing.
Buffering the Ca2+ rise can prevent, or at least delay, the
onset of apoptosis [13]. The study by Assefa et al. [12]
suggests that the Ca2+ elevation occurs because of IP3
receptor cleavage. Consistent with this, the DT40 cells
expressing normal type 1 IP3 receptors, but not the
caspase-resistant mutant, displayed increased cytoso-
lic Ca2+ following staurosporine addition. The Ca2+ rise
was blocked by a specific caspase 3 inhibitor [12].
These data reveal that type 1 IP3 receptors are critical
targets for caspase cleavage, and the subsequent
unregulated release of Ca2+ accelerates cell death. 
In an alternative model for IP3 receptor activation
during apoptosis that is not reliant on caspase cleav-
age, cytochrome C released from mitochondria is sug-
gested to control Ca2+ movement through IP3
receptors. Cytochrome C was shown to bind IP3 recep-
tors and reduce the Ca2+-dependent inhibition of
channel opening [14]. Within a cell undergoing apopto-
sis, this generates a positive feedback loop, whereby
Ca2+ stimulates cytochrome C release and vice versa.
The significance of this amplification mechanism was
demonstrated by expressing a peptide corresponding
to the carboxy-terminal portion of IP3 receptors, where
cytochrome C binds: this peptide buffers cytochrome C
as it emerges from mitochondria and prevents its inter-
action with functional IP3 receptors. As predicted, the
carboxy-terminal IP3 receptor fragment acted in a dom-
inant-negative fashion and substantially reduced both
the amplitude of Ca2+ signals and release of
cytochrome C following addition of staurosporine [14].
These studies all point to a crucial role of IP3
receptors in the generation of Ca2+ signals that drive
cells into apoptosis. But it is unclear which model
accounts for the activation of Ca2+ release. The
schemes involving caspase 3 cleavage and cytochrome
C binding appear to be mutually exclusive, in that IP3
receptors cleaved by caspase 3 are constitutively open
and so presumably do not require cytochrome C
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Figure 1. Some of the interactions that
lead to recruitment of IP3 receptors during
apoptosis. 
The positive feedback between IP3 recep-
tor-mediated Ca2+ release and mitochon-
dria underlies the generation of Ca2+
signals that accelerate the rate of cell
death. The apoptosis-inducing cycle of
Ca2+ between IP3 receptors and mitochon-
dria can be initiated by a variety of mecha-
nisms, including non-specific entry of Ca2+
following membrane damage.
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binding. On the other hand, cytochrome C only regu-
lates channels that can still bind IP3, but caspase 3
cleavage removes the IP3 binding site. It is possible that
caspase 3 and cytochrome C have a synergystic action,
work sequentially or target different IP3 populations. 
IP3 receptors are by no means the only mechanism
by which cellular Ca2+ can be elevated during cell
death. Several other types of channel are known to
transport Ca2+ and promote apoptosis. In particular,
members of the TRPM family — melastatin-related tran-
sient receptor potential cation channels — underlie Ca2+
fluxes and cell death in neurons. And IP3 receptors are
not the only targets for caspases. It has been demon-
strated that the Ca2+ATPases on the plasma membrane
are cleaved by caspases, thus preventing normal home-
ostasis and consequently causing Ca2+ elevation [15].
Damage to cellular membranes can cause a leak of
Ca2+ into the cytoplasm, which often leads to the acti-
vation of Ca2+-dependent cysteine endopeptidases
known as calpains. These proteases have been shown
to activate caspases, cause cytochrome C release and
promote cell death. 
Interaction with the Anti-Apoptotic Protein Bcl-2
As Ca2+ signals emanating from the ER via IP3 receptors
are critical for induction of cell death, regulating Ca2+
release is an obvious way for cells to control apoptotic
signalling. Consistent with this, the anti-apoptotic
protein Bcl-2 has been shown to reduce ER Ca2+
release, decrease mitochondrial Ca2+ uptake and abro-
gate cell death. Bcl-2 is a small integral membrane
protein that localizes to both mitochondria and the ER
[16] and so is present at the key locations where Ca2+
transport occurs. It has been proposed that Bcl-2
decreases the Ca2+ content of the ER and thereby
reduces the flux of Ca2+ from IP3 receptors to mito-
chondria. But whilst it is clear that manipulating ER
luminal Ca2+ concentration can alter the sensitivity of
cells to apoptosis [17], whether Bcl-2 works via this
mechanism is controversial [18]. 
An alternative scheme by which Bcl-2 might regulate
IP3 receptor activity was recently highlighted by the
observation of a direct interaction between these pro-
teins [19]. Expression of Bcl-2 in a T-cell line was found
to inhibit Ca2+ signals in response to a membrane-per-
meant IP3 analogue, without altering the ER Ca2+
content. Furthermore, the open probability of purified
IP3 receptors incorporated into planar lipid bilayers was
reduced by addition of recombinant Bcl-2. The direct
coupling of these proteins within cells was substanti-
ated using bi-directional co-immunoprecipitation of IP3
receptors (isoforms 1 and 3) and Bcl-2. Where Bcl-2
binds to IP3 receptors, and how it alters channel activ-
ity, are not known. Although the experiments in planar
lipid bilayers suggest that the interaction is direct, it is
plausible that within cells Bcl-2 also acts to scaffold
other proteins to IP3 receptors. For example, it has been
proposed that Bcl-2 docks calcineurin with IP3 recep-
tors [20]. By regulating the phosphorylation status of IP3
receptors, calcineurin could modulate Ca2+ release. 
Without the participation of IP3 receptors, cells are
either resistant to pro-apoptotic stimulation or cell
death is dramatically slowed. The precise mechanism
by which IP3 receptors are recruited during apoptosis is
uncertain. It is clear, however, that Ca2+ accelerates the
rate of apoptosis, and that IP3 receptors provide an
amplification mechanism by which sustained Ca2+
signals can arise (Figure 1). 
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